Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 1
2018 1
2020 1
2021 1
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
A mechanism of self-lipid endocytosis mediated by the receptor Mincle.
Kostarnoy AV, Gancheva PG, Kireev II, Soloviev AI, Lepenies B, Kulibin AY, Malolina EA, Scheglovitova ON, Kondratev AV, Sokolova MV, Vorobyeva D, Filippova N, Kapkaeva MR, Lagarkova MA, Metalnikov PS, Riabenko E, Grumov DA, Bobrov MA, Vasilieva E, Naroditsky BS, Gintsburg AL. Kostarnoy AV, et al. Among authors: vorobyeva d. Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2120489119. doi: 10.1073/pnas.2120489119. Epub 2022 Jul 22. Proc Natl Acad Sci U S A. 2022. PMID: 35867828 Free PMC article.
Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy.
Lebedeva A, Molodtsov I, Anisimova A, Berestovskaya A, Dukhin O, Elizarova A, Fitzgerald W, Fomina D, Glebova K, Ivanova O, Kalinskaya A, Lebedeva A, Lysenko M, Maryukhnich E, Misyurina E, Protsenko D, Rosin A, Sapozhnikova O, Sokorev D, Shpektor A, Vorobyeva D, Vasilieva E, Margolis L. Lebedeva A, et al. Among authors: vorobyeva d. Int J Mol Sci. 2022 Jul 19;23(14):7937. doi: 10.3390/ijms23147937. Int J Mol Sci. 2022. PMID: 35887283 Free PMC article.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.
Molodtsov IA, Kegeles E, Mitin AN, Mityaeva O, Musatova OE, Panova AE, Pashenkov MV, Peshkova IO, Alsalloum A, Asaad W, Budikhina AS, Deryabin AS, Dolzhikova IV, Filimonova IN, Gracheva AN, Ivanova OI, Kizilova A, Komogorova VV, Komova A, Kompantseva NI, Kucheryavykh E, Lagutkin DА, Lomakin YA, Maleeva AV, Maryukhnich EV, Mohammad A, Murugin VV, Murugina NE, Navoikova A, Nikonova MF, Ovchinnikova LA, Panarina Y, Pinegina NV, Potashnikova DM, Romanova EV, Saidova AA, Sakr N, Samoilova AG, Serdyuk Y, Shakirova NT, Sharova NI, Sheetikov SA, Shemetova AF, Shevkova LV, Shpektor AV, Trufanova A, Tvorogova AV, Ukrainskaya VM, Vinokurov AS, Vorobyeva DA, Zornikova KV, Efimov GA, Khaitov MR, Kofiadi IA, Komissarov AA, Logunov DY, Naigovzina NB, Rubtsov YP, Vasilyeva IA, Volchkov P, Vasilieva E. Molodtsov IA, et al. Among authors: vorobyeva da. Clin Infect Dis. 2022 Aug 24;75(1):e1-e9. doi: 10.1093/cid/ciac278. Clin Infect Dis. 2022. PMID: 35435222 Free PMC article.
15 results